@FierceMedDev: St. Jude Medical to study neuromodulation combo treatment for back and leg pain. More | Follow @FierceMedDev
@MarkHFierce: Patients' attorneys say J&J either lost or wiped out vital docs about vaginal mesh implants vital to their lawsuits. Story | Follow @MarkHFierce
@MichaelGFierce: Researchers' pitch: An injectable, sustained-release rotator cuff treatment. News | Follow @MichaelGFierce
@GalenMoore: Boston hand-wringing alert: Celgene, Lilly back $100M VC fund for NY biotech startups. Story | Follow @GalenMoore
> Cernostics in Pittsburgh raised a $1.4 million Series B financing to speed up development of its diagnostic designed to predict the risk of esophageal cancer in patients with Barrett's esophagus. Item
> Uroplasty ($UPI), a maker of devices to treat incontinence, said it can take advantage of expanded coverage for a key treatment of overactive bladder from both Medicare and private insurers. Item
> Britain's National Health Service is under fire for not using an effective method to sterilize surgical instruments contaminated with variant Creutzfeldt-Jakob disease, a degenerative neurological disorder. Story
> Apollo Endosurgery, a 2012 Fierce 15 winner, has finalized its purchase of Allergan's ($AGN) obesity intervention business in a deal worth up to $110 million. Story
> Researchers are using crowdfunding to propel development of a device designed to help breast cancer patients and their doctors determine if chemotherapy is working. Story
Biotech News
@FierceBiotech: Organogenesis preps 'heart breaking' cuts as Medicare slashes reimbursement. More | Follow @FierceBiotech
@JohnCFierce: Hey, you VCs looking at getting into the NY fund, drop me a line with your thoughts. | Follow @JohnCFierce
@DamianFierce: As everyone goes public, Zafgen goes it alone, raises another $45M in Series E cash. Item | Follow @DamianFierce
@EmilyMFierce: ICYMI: Key hep C protein revealed, paving the way for new vaccines. News | Follow @EmilyMFierce
> 5AM Ventures has $250M and an eye out for early-stage biotechs. News
> Medicines Co. buys out Rempex's pipeline for hospital-acquired infections. Story
> Immunotherapy startup lands $120M Series A for cancer-killing drugs. More
Pharma News
@FiercePharma: Boehringer Ingelheim looks for a buyer for its troubled Bedford operation. News | Follow @FiercePharma
@EricPFierce: Will wonders--and AstraZeneca's patent battles over Prilosec--never cease? Apotex ordered to pay $76M. News | Follow @EricPFierce
@CarlyHFierce: Can Celgene, Eli Lilly and GE Ventures help turn NYC into a biotech hub? Story | Follow @CarlyHFierce
> Pfizer cutting 150 more jobs in Ireland in face of weak sales. More
> Teva has a 'clear strategy,' Desheh claims. Piece
Drug Delivery News
> Study: 'Worm-shaped' nanoparticles best at infiltrating breast cancer. More
> BioDelivery Sciences pushes diabetic pain gel to PhIII with FDA nod. News
> Danish nanorobots offer hot, cold delivery. Article
> Researchers' pitch: An injectable, sustained-release rotator cuff treatment. Piece
> Unilife bags Novartis deal for injectable tech. Story
> Bind founders publish data showing nanomed transport ability. Item
Diagnostics News
> LabCorp launch heightens crowding of BRCA predictive cancer test market. Story
> Biodesix grabs an $8.3M Series E for personalized lung cancer treatment test. Report
> Investors panic over BioReference Laboratories' reimbursement woes. Article
> U.K. team speeds brain cancer diagnostic process. News
> BioMérieux, Biocartis shut down molecular Dx development partnership. More
> Myriad Genetics inches closer to acquiring Crescendo Bioscience. Item